Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and l-arginine after DNA analysis produced a definitive diagnosis

被引:5
|
作者
Unita, Satoshi [1 ]
Hirashima, Noboru [1 ]
Shimada, Masaaki [1 ]
Tsunekawa, Takuya [1 ]
Tanaka, Daiki [1 ]
Kondo, Takashi [1 ]
Urata, Noboru [1 ]
Kondo, Hisashi [1 ]
Saito, Masashi [1 ]
Iwase, Hiroaki [1 ]
Ito, Shogo [2 ]
Togawa, Takao [2 ]
Saitoh, Shinji [2 ]
Tanaka, Yasuhito [3 ,4 ]
机构
[1] Natl Hosp Org Nagoya Med Ctr, Dept Gastroenterol, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[4] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan
关键词
Hyperammonemia; Citrin deficiency; Adult-onset type II citrullinemia; l-Arginine; Medium-chain triglycerides; ASPARTATE GLUTAMATE CARRIER; CITRIN DEFICIENCY; SODIUM PYRUVATE; SLC25A13; GENE; LIVER; THERAPY; MUTATIONS; FREQUENCY; ENCEPHALOPATHY; IDENTIFICATION;
D O I
10.1007/s12328-019-01083-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 60-year-old male, who exhibited finger tremors, obnubilation, and hyperammonemia (409 mu g/dL), was admitted to our hospital. Initially, we suspected that a portosystemic shunt had caused his hyperammonemia. However, his symptoms did not improve after balloon-occluded retrograde transvenous obliteration. He was subsequently found to have some peculiar eating habits, including a fondness for bean curd and peanuts, and an aversion to alcohol and sweets. Furthermore, marked citrullinemia (454.2 nmol/mL) was revealed, which led us to suspect adult-onset type II citrullinemia (CTLN2). DNA analysis of the patient and his mother, son, and daughter confirmed that he was homozygous for the c.852_855del mutation in the SLC25A13 gene, and his relatives were heterozygous for the c.852_855del mutation, which led to a definitive diagnosis. A low-carbohydrate diet and the administration of l-arginine ameliorated his symptoms. It is important to be aware that CTLN2 can occur in elderly patients. Thus, patients who exhibit symptoms of CTLN2 should be interviewed about their dietary habits and subjected to plasma amino acid analysis. In this report, we consider the metabolic disorders seen in citrin deficiency and the associated compensatory mechanisms in relation to the clinical features and treatment of CTLN2.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 7 条
  • [1] Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and l-arginine after DNA analysis produced a definitive diagnosis
    Satoshi Unita
    Noboru Hirashima
    Masaaki Shimada
    Takuya Tsunekawa
    Daiki Tanaka
    Takashi Kondo
    Noboru Urata
    Hisashi Kondo
    Masashi Saito
    Hiroaki Iwase
    Shogo Ito
    Takao Togawa
    Shinji Saitoh
    Yasuhito Tanaka
    Clinical Journal of Gastroenterology, 2020, 13 : 823 - 833
  • [2] Three cases of adult-onset type II citrullinemia treated with different therapies: Efficacy of sodium pyruvate and low-carbohydrate diet
    Kogure, Takayuki
    Kondo, Yasuteru
    Kakazu, Eiji
    Ninomiya, Masashi
    Kimura, Osamu
    Kobayashi, Nao
    Shimosegawa, Tooru
    HEPATOLOGY RESEARCH, 2014, 44 (06) : 707 - 712
  • [3] Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia
    Hayasaka, Kiyoshi
    Numakura, Chikahiko
    Toyota, Kentaro
    Kakizaki, Satoru
    Watanabe, Hisayoshi
    Haga, Hiroaki
    Takahashi, Hiroshi
    Takahashi, Yoshimi
    Kaneko, Mieko
    Yamakawa, Mitsunori
    Nunoi, Hiroyuki
    Kato, Takeo
    Ueno, Yoshiyuki
    Mori, Masatomo
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2014, 1 : 42 - 50
  • [4] Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia
    Hayasaka, Kiyoshi
    Numakura, Chikahiko
    Yamakawa, Mitsunori
    Mitsui, Tetsuo
    Watanabe, Hisayoshi
    Haga, Hiroaki
    Yazaki, Masahide
    Ohira, Hiromasa
    Ochiai, Yasuo
    Tahara, Toshiyuki
    Nakahara, Tamio
    Yamashiki, Noriyo
    Nakayama, Takahiro
    Kon, Takashi
    Mitsubuchi, Hiroshi
    Yoshida, Hiroshi
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (05) : 777 - 784
  • [5] Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia
    Okano, Yoshiyuki
    Okamoto, Miki
    Yazaki, Masahide
    Inui, Ayano
    Ohura, Toshihiro
    Murayama, Kei
    Watanabe, Yoriko
    Tokuhara, Daisuke
    Takeshima, Yasuhiro
    MOLECULAR GENETICS AND METABOLISM, 2021, 133 (01) : 63 - 70
  • [6] Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease
    Imamura, Y
    Kobayashi, K
    Shibatou, T
    Aburada, S
    Tahara, K
    Kubozono, O
    Saheki, T
    HEPATOLOGY RESEARCH, 2003, 26 (01) : 68 - 72
  • [7] Recovery from marked altered consciousness in a patient with adult-onset type II citrullinemia diagnosed by DNA analysis and treated with a living related partial liver transplantation
    Takashima, Y
    Koide, M
    Fukunaga, H
    Iwai, M
    Miura, M
    Yoneda, R
    Fukuda, T
    Kobayashi, K
    Saheki, T
    INTERNAL MEDICINE, 2002, 41 (07) : 555 - 560